83 research outputs found
Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: Impact of patient characteristics and timing of transplant
Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection
The relative contribution of human cytomegalovirus (HMCV)-specific CD4(+) and CD8(+) T cells to the control of HCMV infection in hematopoietic stem cell transplant (HSCT) recipients is still controversial. HCMV reactivation and HCMV-specific CD4(+) and CD8(+) T cell reconstitution were monitored for 1 year in 63 HCMV-seropositive patients receiving HSCT. HCMV reactivation was detected in all but 2 patients. In 20 of 63 (31.7%) patients (group 1) HCMV infection resolved spontaneously, whereas 32 of 63 (50.8%) patients (group 2) controlled the infection after a single short-course of pre-emptive therapy and the remaining 9 (14.3%) patients (group 3) suffered from relapsing episodes of HCMV infection, requiring multiple courses of antiviral therapy. The kinetics and magnitude of HCMV-specific CD8(+) T cell reconstitution were comparable among the 3 groups, but HCMV-specific CD4(+) T cells were lower in number in patients requiring antiviral treatment. HCMV-seronegative donors, as well as unrelated donors (receiving antithymocyte globulin) and acute graft-versus-host disease (GVHD) were associated with both delayed HCMV-specific CD4(+) T cell reconstitution and severity of infection. Conversely, these risk factors had no impact on HCMV-specific CD8(+) T cells. Eight patients with previous GVHD suffered from HCMV gastrointestinal disease, although in the presence of HCMV-specific CD4(+) and CD8(+) systemic immunity and undetectable HCMV DNA in blood. Reconstitution of systemic HCMV-specific CD4(+) T cell immunity is required for control of HCMV reactivation in adult HSCT recipients, but it may not be sufficient to prevent late-onset organ localization in patients with GVHD. HCMV-specific CD8(+) T cells contribute to control of HCMV infection, but only after HCMV-specific CD4(+) T cell reconstitution
Teaching cancer imaging in the era of precision medicine: Looking at the big picture
The role of imaging in cancer diagnosis and treatment has evolved at the same rapid pace as cancer management. Over the last twenty years, with the advancement of technology, oncology has become a multidisciplinary field that allows for researchers and clinicians not only to create individualized treatment options for cancer patients, but also to evaluate patients\u27 response to therapy with increasing precision. Familiarity with these concepts is a requisite for current and future radiologists, as cancer imaging studies represent a significant and growing component of any radiology practice, from tertiary cancer centers to community hospitals. In this review we provide the framework to teach cancer imaging in the era of genomic oncology. After reading this article, readers should be able to illustrate the basics cancer genomics, modern cancer genomics, to summarize the types of systemic oncologic therapies available, their patterns of response and their adverse events, to discuss the role of imaging in oncologic clinical trials and the role of tumor response criteria and to display the future directions of oncologic imaging
Decellularized silk fibroin scaffold primed with adipose mesenchymal stromal cells improves wound healing in diabetic mice
Introduction:
Silk fibroin (SF) scaffolds have been shown to be a suitable substrate for tissue engineering
and to improve tissue regeneration when cellularized with mesenchymal stromal cells
(MSCs). We here demonstrate, for the first time, that electrospun nanofibrous SF patches,
cellularized with human adipose-derived MSCs (Ad-MSCs-SF) or decellularized (D-Ad-
MSCs-SF) are effective in the treatment of skin wounds, improving skin regeneration in
db/db diabetic mice.
Methods:
The conformational and structural analyses of SF and D-Ad-MSCs-SF patches were
performed by scanning electron microscopy, confocal microscopy, Fourier transform infrared spectroscopy and differential scanning calorimetry. Wounds were performed by a 5mm
punch biopsy tool on the mouse\u2019s back. Ad-MSCs-SF and D-Ad-MSCs-SF patches were
transplanted and the efficacy of treatments was assessed by measuring the wound closure
area, by histological examination and by gene expression profile. We further investigated the
in vitro angiogenic properties of Ad-MSCs-SF and D-Ad-MSCs-SF patches by affecting
migration of human umbilical vein endothelial cells (HUVECs), keratinocytes (KCs) and
dermal fibroblasts (DFs), through the aortic ring assay and, finally, by evaluating the release
of angiogenic factors.
Results:
We found that Ad-MSCs adhere and grow on SF, maintaining their phenotypic mesenchymal
profile and differentiation capacity. Conformational and structural analyses on SF and D-Ad-
MSCs-SF samples, showed that sterilization, decellularization, freezing and storing did not
affect the SF structure. When grafted in wounds of diabetic mice, both Ad-MSCs-SF and DAd-
MSCs-SF significantly improved tissue regeneration, reducing the wound area
respectively by 40% and 35%, within three days, completing the process in around 10 days
compared to 15-17 days of controls. RT2 gene profile analysis of the wounds treated with Ad-
MSCs-SF and D-Ad-MSCs-SF showed an increment of genes involved in angiogenesis and
matrix remodelling. Finally, Ad-MSCs-SF and D-Ad-MSCs-SF co-cultured with HUVECs,
DFs and KCs, preferentially enhanced the HUVECs\u2019 migration and the release of angiogenic
factors stimulating microvessel outgrowth in the aortic ring assay.
Conclusions:
Our results highlight for the first time that D-Ad-MSCs-SF patches are almost as effective as
Ad-MSCs-SF patches in the treatment of diabetic wounds, acting through a complex
mechanism that involves stimulation of angiogenesis. Our data suggest a potential use of DAd-
MSCs-SF patches in chronic diabetic ulcers in humans
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Background Gram-negative bacteremia (GNB) is a major cause of illness and death after hematopoietic stem cell transplantation (HSCT), and updated epidemiological investigation is advisable. Methods We prospectively evaluated the epidemiology of pre-engraftment GNB in 1118 allogeneic HSCTs (allo-HSCTs) and 1625 autologous HSCTs (auto-HSCTs) among 54 transplant centers during 2014 (SIGNB-GITMO-AMCLI study). Using logistic regression methods. we identified risk factors for GNB and evaluated the impact of GNB on the 4-month overall-survival after transplant. Results The cumulative incidence of pre-engraftment GNB was 17.3% in allo-HSCT and 9% in auto-HSCT. Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were the most common isolates. By multivariate analysis, variables associated with GNB were a diagnosis of acute leukemia, a transplant from a HLA-mismatched donor and from cord blood, older age, and duration of severe neutropenia in allo-HSCT, and a diagnosis of lymphoma, older age, and no antibacterial prophylaxis in auto-HSCT. A pretransplant infection by a resistant pathogen was significantly associated with an increased risk of posttransplant infection by the same microorganism in allo-HSCT. Colonization by resistant gram-negative bacteria was significantly associated with an increased rate of infection by the same pathogen in both transplant procedures. GNB was independently associated with increased mortality at 4 months both in allo-HSCT (hazard ratio, 2.13; 95% confidence interval, 1.45-3.13; P <.001) and auto-HSCT (2.43; 1.22-4.84; P =.01). Conclusions Pre-engraftment GNB is an independent factor associated with increased mortality rate at 4 months after auto-HSCT and allo-HSCT. Previous infectious history and colonization monitoring represent major indicators of GNB. Clinical Trials registration NCT02088840
Recommended from our members
Acoustic radiation force impulse elastography for liver iron overload in β-thalassemia major: Is it going to cut it?
In this issue ofJCU, Kaban and Damar investigated the correlationand agreement between T2*-weighted MRI, ARFI measurementresults of liver and plasma ferritin levels in 40 pediatric patients withβ-thalassemia. The authors demonstrated a strong negative correla-tion between T2*-weighted MRI and ARFI measurement, a moderatenegative correlation between T2*-weighted MRI and plasma ferritinlevels, and a strong positive correlation between ARFI values andplasma ferritin levels. The results of this article differ from theresults of the study by Wurschli et al. possibly due to the different populations: while Kaban et al. investigated patients withβ-thalasse-mia, Wurschli et al. investigated patients who had undergone bonemarrow transplant, which are prone to suffer from additional causesof liver injury, including graft versus host disease, sinusoid obstructionsyndrome, and drug induced liver disease. Although the data stemming from this study are still insufficient to propose the use of ARFI as a diagnostic technique to monitor ironoverload in patients withβ-thalassemia, this article is a step towardfurther expanding the potential applications of elastography
- …